Your nameFriend's name
Your emailFriend's email

Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-malignant pain

Central Hospital for the Univerisity of Sherbrooke, S-Hotel-Dieu, Sherbrooke, Quebec, Canada, Brigham and Women’s Hospital, Boston, Massachusetts and Wyeth Research, Collegeville, Pennsylvania, United States of America

ASA member / Anaesthesia and Intensive Care subscriber

If you are a member of the ASA or subscribe to the Anaesthesia and Intensive Care Journal please login to view entire article.

Register for free access

Please register for free access to this article.

Already registered

Click here to login now.